Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/11/2026 | Q4 | $168.5M | -- | -- | $0.07 | -- |
| 11/05/2025 | Q3 | $169.5M | $155.8M | -$0.34 | $0.06 | -$0.39 |
| 08/06/2025 | Q2 | $155.5M | $153.7M | $0.43 | $0.02 | $0.42 |
| 05/08/2025 | Q1 | $165.5M | $172.2M | -$1.25 | $0.08 | -$1.33 |
| 03/12/2025 | Q4 | $173M | $193.5M | -$0.02 | $0.15 | -$0.17 |
| 11/07/2024 | Q3 | $181M | $186.3M | $0.91 | $0.15 | $0.76 |
| 08/09/2024 | Q2 | $177.2M | $205.5M | -$0.11 | $0.20 | -$0.32 |
| 05/01/2024 | Q1 | $175.5M | $207.3M | -$0.53 | $0.17 | -$0.70 |
| 03/06/2024 | Q4 | $182.4M | $336.4M | $0.81 | $0.24 | $0.57 |
| 11/01/2023 | Q3 | -- | $222.1M | -$0.60 | -- | -- |
| 08/02/2023 | Q2 | -- | $208.5M | $0.33 | -- | -- |
| 05/03/2023 | Q1 | -- | $216.5M | -$0.08 | -- | -- |
| 02/22/2023 | Q4 | -- | $243.6M | $0.90 | -- | -- |
| 11/02/2022 | Q3 | -- | $262.2M | $2.34 | -- | -- |
| 08/03/2022 | Q2 | -- | $293.8M | $0.52 | -- | -- |
| 05/04/2022 | Q1 | -- | $255.9M | -$0.71 | -- | -- |
| 02/22/2022 | Q4 | -- | $224.5M | $0.11 | -- | -- |
| 11/02/2021 | Q3 | -- | $143.3M | $0.12 | -- | -- |
| 08/03/2021 | Q2 | -- | $154.9M | -$0.16 | -- | -- |
| 05/04/2021 | Q1 | -- | $147.7M | -$0.27 | -- | -- |
| 02/23/2021 | Q4 | -- | $101M | -$0.80 | -- | -- |
| 11/03/2020 | Q3 | -- | $101.3M | -$0.24 | -- | -- |
| 08/04/2020 | Q2 | -- | $75.7M | -$0.81 | -- | -- |
| 05/06/2020 | Q1 | -- | $128M | -$1.45 | -- | -- |
| 02/26/2020 | Q4 | -- | $163.7M | -$0.09 | -- | -- |
| 11/07/2019 | Q3 | -- | $149.2M | $0.65 | -- | -- |
| 08/07/2019 | Q2 | -- | $142.8M | $0.39 | -- | -- |
| 05/08/2019 | Q1 | -- | $141.8M | -$0.42 | -- | -- |
| 03/06/2019 | Q4 | -- | $153.2M | $1.56 | -- | -- |
| 11/07/2018 | Q3 | -- | $161.9M | -$0.66 | -- | -- |
| 08/22/2018 | Q2 | -- | $144.1M | -$0.41 | -- | -- |
| 03/31/2018 | Q1 | -- | $131.9M | $0.02 | -- | -- |
| 12/31/2017 | Q4 | -- | $55.4M | -$1.23 | -- | -- |
| 09/30/2017 | Q3 | -- | $69.9M | -$0.46 | -- | -- |
| 06/30/2017 | Q2 | -- | $134.7M | $0.08 | -- | -- |
| 03/31/2017 | Q1 | -- | $115.4M | -$14.99 | -- | -- |
| 12/31/2016 | Q4 | -- | $97.9M | -$2.03 | -- | -- |
| 09/30/2016 | Q3 | -- | $113.2M | -$2.99 | -- | -- |
| 06/30/2016 | Q2 | -- | $108.6M | $0.21 | -- | -- |
| 03/31/2016 | Q1 | -- | $91.3M | -$34.17 | -- | -- |
| 12/31/2015 | Q4 | -- | $115.2M | -$1.55 | -- | -- |
Berry Corp. reported $155.8M worth of top line sales in its most recent quarter.
Berry Corp. announced earnings per share of -$0.34 which represents a miss of analyst forecast a $0.06 per share.
Berry Corp. reported $36.9M that represents $0.48 per share over the last quarter.
Berry Corp.'s earnings are forecast to grow from $0.25 per share to $0.57 per share next year representing an increase of 4%.
Berry Corp.'s next earnings date is March 11, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.